These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10403383)

  • 1. Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.
    Noakes KL; Teisserenc HT; Lord JM; Dunbar PR; Cerundolo V; Roberts LM
    FEBS Lett; 1999 Jun; 453(1-2):95-9. PubMed ID: 10403383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
    Smith DC; Gallimore A; Jones E; Roberts B; Lord JM; Deeks E; Cerundolo V; Roberts LM
    J Immunol; 2002 Jul; 169(1):99-107. PubMed ID: 12077234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
    Donnelly JJ; Ulmer JB; Hawe LA; Friedman A; Shi XP; Leander KR; Shiver JW; Oliff AI; Martinez D; Montgomery D
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3530-4. PubMed ID: 7682709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin.
    Lee RS; Tartour E; van der Bruggen P; Vantomme V; Joyeux I; Goud B; Fridman WH; Johannes L
    Eur J Immunol; 1998 Sep; 28(9):2726-37. PubMed ID: 9754560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.
    Goletz TJ; Klimpel KR; Arora N; Leppla SH; Keith JM; Berzofsky JA
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12059-64. PubMed ID: 9342362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of an exogenous antigen by major histocompatibility complex class I molecules.
    Ulmer JB; Donnelly JJ; Liu MA
    Eur J Immunol; 1994 Jul; 24(7):1590-6. PubMed ID: 8026520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Cox JH; Yewdell JW; Eisenlohr LC; Johnson PR; Bennink JR
    Science; 1990 Feb; 247(4943):715-8. PubMed ID: 2137259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol.
    Cao H; Agrawal D; Kushner N; Touzjian N; Essex M; Lu Y
    J Infect Dis; 2002 Jan; 185(2):244-51. PubMed ID: 11807699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of antigens to the MHC class I pathway using bacterial toxins.
    Goletz TJ; Klimpel KR; Leppla SH; Keith JM; Berzofsky JA
    Hum Immunol; 1997 May; 54(2):129-36. PubMed ID: 9297531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway.
    Neumeister C; Nanan R; Cornu TI; Lüder CGK; Ter Meulen V; Naim H; Niewiesk S
    J Gen Virol; 2001 Feb; 82(Pt 2):441-447. PubMed ID: 11161284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo.
    Schutze-Redelmeier MP; Gournier H; Garcia-Pons F; Moussa M; Joliot AH; Volovitch M; Prochiantz A; Lemonnier FA
    J Immunol; 1996 Jul; 157(2):650-5. PubMed ID: 8752913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.
    McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ
    J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.
    Kreiter S; Selmi A; Diken M; Sebastian M; Osterloh P; Schild H; Huber C; Türeci O; Sahin U
    J Immunol; 2008 Jan; 180(1):309-18. PubMed ID: 18097032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.